Dominique I. B.
- Country
- France
- Department
- Hôpital de jour - Service de Pneumologie et Soins Intensifs
Research Overview
- Long-term Safety and Tolerability Evaluation of Inhaled Treprostinil in Patients with Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis
- Phase 2 Randomized, Double-Blind, Placebo-Controlled Study on the Efficacy and Safety of MBS2320 in Idiopathic Pulmonary Fibrosis Patients
- Randomized, Double‑Blind, Placebo‑Controlled Trial of Oral CHIT1 Inhibitor OATD‑01 in Patients with Active Pulmonary Sarcoidosis (KITE Study)
Data & Insights
Has run more than one trial at 131 of 203 partner sites.
Specializations
Pulmonary Medicine
The investigator specializes in studying therapeutic approaches for pulmonary sarcoidosis, with particular emphasis on evaluating innovative treatments for active forms of the condition.
- Granulomatous Inflammation Management
- Pulmonary Parenchyma Assessment
- Advanced Imaging Techniques
Research activities focus on assessing inflammatory responses in lung tissue using PET/CT imaging methodologies.
Inflammatory Disorders
The investigator demonstrates expertise in inflammatory disease therapeutics, particularly targeting granulomatous conditions affecting the respiratory system.
- Novel Treatment Evaluation
- Anti-inflammatory Interventions
- Disease Activity Monitoring
Specialized interest in developing therapeutic strategies for chronic inflammatory lung conditions.
Diagnostic Imaging
Expertise in utilizing advanced molecular imaging techniques for assessing treatment responses in pulmonary conditions.
- FDG PET/CT Applications
- Treatment Response Assessment
- Inflammation Monitoring
Focus on implementing imaging biomarkers for evaluating therapeutic efficacy in respiratory disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.